Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: Phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen

D. R. Parkinson, R. I. Fisher, A. A. Rayner, E. Paietta, K. A. Margolin, G. R. Weiss, J. W. Mier, M. Sznol, E. R. Gaynor, M. H. Bar, R. Gucalp, D. H. Boldt, B. Mills, M. J. Hawkins

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: Phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences